CJC-1295 (without DAC) and Cyclic Glycine-Proline Interaction

Monitor
Mechanism-based 47% confidence

CJC-1295 (without DAC) and Cyclic Glycine-Proline have an interaction requiring monitoring for interaction with 47% confidence. Both CJC-1295 (without DAC) and Cyclic Glycine-Proline affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss
ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

Cyclic Glycine-Proline

IGF-1 Bioavailability Regulator & Neuroprotective Peptide

Competes with IGF-1 for IGFBP-3 binding, normalizing bioavailable IGF-1 levels. Acts as positive allosteric modulator of AMPA and GABA-A receptors.

Half-life: Extended stability (more stable than linear GPE precursor) Typical dose: 20-100 μg daily (or 300mg blackcurrant extract 2x daily) cognitive, longevity
bdnfgabaigf1 insulin disrupting
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Brain
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (CJC-1295 (without DAC), Cyclic Glycine-Proline). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Cyclic Glycine-Proline?

Yes, but with caution. Both CJC-1295 (without DAC) and Cyclic Glycine-Proline affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is CJC-1295 (without DAC) and Cyclic Glycine-Proline safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and Cyclic Glycine-Proline?

Both CJC-1295 (without DAC) and Cyclic Glycine-Proline affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and Cyclic Glycine-Proline?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Cyclic Glycine-Proline has a half-life of Extended stability (more stable than linear GPE precursor). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs Cyclic Glycine-Proline

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.